Aultman Health Foundation   Report issue

Foundation Phase 2 Phase 3 Phase 4
Founded: Canton OH United States (1969)

Organization Overview

First Clinical Trial
2005
NCT00243984
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Aultman Health Foundation | Muhammad Chaudhry, MD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Coronary Artery Disease (Phase 4)

Diabetes Mellitus, Type 2 (Phase 3)

Heart Failure (Phase 2)

Metabolic Syndrome (Phase 3)

Muscle Cramp (Phase 4)

Pain, Postoperative (Phase 4)

Peripheral Vascular Diseases (Phase 4)

Spasm (Phase 4)

Syndrome (Phase 3)

Weight Loss (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 10